Demonstrates the effectiveness of light metal pyrazolates for CO2 capture and transformation into cyclic carbonates, highlighting their catalytic potential.
Recent advances have shown that light metal pyrazolate complexes not only achieve high CO₂ uptake but are also able to convert epoxides and CO₂ to cyclic carbonates catalytically. Surface organometallic chemistry (SOMC) combines reactive metal complexes with the durability and robustness of a support material to form environmentally even more benign materials for CO₂ capture and conversion. In this study, light metal pyrazolates with a variety of oxidation states and ionic radii were grafted onto mesoporous silica SBA-15₅₀₀ affording the hybrid materials [Mg(pztBu2)₂]₂@SBA-15₅₀₀, Al(pztBu2)₃@SBA-15₅₀₀, Ti+IV(pzMe2)₄@SBA-15₅₀₀, and Ti+III(pztBu2)₃@SBA-15₅₀₀. The hybrid materials were characterized via N₂ physisorption, elemental analysis, ICP/OES, DRIFTS, and solid-state NMR spectroscopy, suggesting successful grafting with monometallic surface species and revealing a CO₂ uptake of up to 11 wt%. In addition, Ti+IV(pzMe2)[OSi(OtBu)₃]₃ was synthesized as a model complex for surface species likely present for Ti+IV(pzMe2)₄@SBA-15₅₀₀. Complex Ti+IV(pzMe2)[OSi(OtBu)₃]₃ is also able to insert CO₂ under the formation of the carbamate complex Ti+IV(CO₂·pzMe2)[OSi(OtBu)₃]₃, emulating material CO₂@Ti+IV(pzMe2)₄@SBA-15₅₀₀. All hybrid materials under study are active catalysts in the cycloaddition of epoxides with CO₂ to form cyclic carbonates. The magnesium hybrid material [Mg(pztBu2)₂]₂@SBA-15₅₀₀ exceeds its homogeneous congener, featuring high conversion even for bulkier epoxides along with a desirable reusability.
No takes yet. Share an insight, caveat, or question.
Kracht et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: